The GABRE antibody is a class of immunoglobulins designed to target the epsilon subunit of the GABA_A receptor, a ligand-gated ion channel critical for synaptic inhibition in the nervous system. GABRE (Gamma-aminobutyric acid receptor subunit epsilon) is encoded by the GABRE gene located on the X chromosome (Xq28) and is expressed in tissues such as the heart, placenta, and brain regions involved in thermoregulation and cardiovascular control . This article synthesizes data on the antibody's structure, experimental uses, and clinical relevance, drawing from peer-reviewed studies and commercial antibody databases.
Antibodies, including those targeting GABRE, adopt a Y-shaped structure composed of two heavy chains and two light chains. The Fab fragment (fragment antigen-binding) mediates specific binding to the GABRE protein, while the Fc region interacts with immune effector molecules . GABRE antibodies are used in research to study:
GABA_A receptor assembly: GABRE is a distinct subunit that modifies receptor pharmacology, conferring resistance to anesthetics and shaping synaptic plasticity .
Neuronal subsets: GABRE-expressing neurons in the preoptic area regulate body temperature and heart rate, as demonstrated by chemogenetic activation experiments .
Chemogenetic modulation of GABRE neurons in the medial preoptic area (mPOA) revealed:
Activation reduces rectal and surface temperatures via mechanisms independent of TRPM2-expressing warm-sensitive neurons .
Inhibition during general anesthesia decreases heart rate by ~20%, indicating baseline GABRE neuronal activity maintains cardiovascular stability .
While GABRE antibodies are not implicated in autoimmune encephalitis, studies on anti-GABA_A receptor encephalitis highlight the broader role of GABA_A receptor subunits in neuroinflammation. Patients with anti-α1/β3 subunit antibodies exhibit seizures, cognitive deficits, and MRI abnormalities, underscoring the receptor's critical role in neuronal function .